Senior Director of Pharmacovigilance

Capricor Therapeutics(1 month ago)

HybridFull TimeDirector$224,058 - $294,291 (estimated)Pharmacovigilance

About this role

The Senior Director of Pharmacovigilance at Capricor Therapeutics will build and lead the global pharmacovigilance function in support of late-stage and commercial cell therapy programs for rare diseases. The role oversees design and governance of safety systems, processes, and documentation to ensure compliance with global regulations. It is a senior leadership position that interfaces extensively with regulatory agencies, internal stakeholders, and external partners as the company advances its lead therapy through and beyond Phase 3. The position may be based in San Diego or remotely with regular collaboration across global teams.

View Original Listing

Required Skills

Pharmacovigilance Management
Drug Safety
Risk Management Plans
Safety Surveillance
Signal Detection
Aggregate Reporting
Regulatory Compliance
Vendor Management
Safety Database Management
Regulatory Submissions

+10 more

Qualifications

Bachelor's Degree in Health Science
MD
PharmD
PhD

About Capricor Therapeutics

capricor.com

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a San Diego–based biotechnology company developing cell- and exosome-based therapeutics for muscular and other select diseases. Its lead candidate, deramiocel (CAP‑1002), is an allogeneic cell therapy currently in Phase 3 clinical development for Duchenne muscular dystrophy. Capricor is also advancing exosome technology as a next‑generation platform, engineering exosomes to deliver nucleic acids and proteins to treat or prevent a variety of diseases. The company focuses on translating these platforms into novel therapeutic and preventive products.